ChinaBio Today's The Week in Review: Eli Lilly and Company Has Big Plans for China

ChinaBio Today -- Eli Lilly (NYSE: LLY) is investing “aggressively” in China, according to the company’s CEO John Lechleiter (see story). To give substance to the claim, Lechleiter said Lilly will launch 15 new products in China over the next five years, has already made $40 million in venture capital investments from its $100 million China VC fund, and, not surprisingly, expects to increase its China revenues this year.